drug

TN-401

Phase 2updated 3mo ago

by $TNYA Tenaya Therapeutics, Inc.

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying TN-401

phase1Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCrecruitingn=15

News(1)

Aardvark's next move after clinical hold; Alumis' verdict on Acelyrin asset
Plus, news about Tenaya’s TN-401 and Taiho’s Inqovi. 📉 Aardvark to unblind rare disease trial following clinical hold: The FDA has placed a full clinical hold on the company's candidate for ...
endpoints · 3mo ago

Data sources

ClinicalTrials.gov

last refreshed 6m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

TN-401

Phase 2updated 3mo ago

by $TNYA Tenaya Therapeutics, Inc.

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying TN-401

phase1Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCrecruitingn=15

News(1)

Aardvark's next move after clinical hold; Alumis' verdict on Acelyrin asset
Plus, news about Tenaya’s TN-401 and Taiho’s Inqovi. 📉 Aardvark to unblind rare disease trial following clinical hold: The FDA has placed a full clinical hold on the company's candidate for ...
endpoints · 3mo ago

Data sources

ClinicalTrials.gov

last refreshed 6m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

TN-401

all catalysts(0)

Trials studying TN-401

News(1)

Report a data issue

comments(0)

TN-401

all catalysts(0)

Trials studying TN-401

News(1)

Report a data issue

comments(0)